Literature DB >> 18350355

Cyclin-dependent kinase 5 is associated with risk for Alzheimer's disease in a Dutch population-based study.

Alejandro Arias-Vásquez1, Yurii S Aulchenko, Aaron Isaacs, Andy van Oosterhout, Kristels Sleegers, Albert Hofman, Christine van Broeckhoven, Ben A Oostra, Monique Breteler, Cornelia M van Duijn.   

Abstract

Although the role of the Cdk5 protein in Alzheimer's disease (AD) is well recognized, there have been relatively few studies investigating genetic variants in the CDK5 gene in AD. In this study, we assessed the association between five previously described single nucleotide polymorphisms (SNPs) in the CDK5 gene and late onset AD by means of logistic regression and haplotype association analyses. Including all prevalent and incident AD cases, we found a significantly increased risk of AD for carriers of the GG genotype of SNP rs2069442 (OR = 1.79, 95 % CI 1.16-2.79, p = 0.001) in those without APOE*4. When limiting the analysis to incident cases without APOE*4, carriers of the GG genotype showed a 1.9-fold increased risk of AD (95 % CI 1.16-3.10, p = 0.003). Variations in the CDK5 gene can be described in 5 haplotype blocks. In our analysis, the haplotype tagged by the G allele of SNP rs2069442 was significantly associated with AD (p = 0.05). In conclusion, our study suggests that CDK5 may be associated with AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350355     DOI: 10.1007/s00415-008-0770-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

2.  Consistency of epidemiologic estimates.

Authors:  Jan J Barendregt; Alewijn Ott
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 4.  Cdk5: one of the links between senile plaques and neurofibrillary tangles?

Authors:  Ming-Sum Lee; Li-Huei Tsai
Journal:  J Alzheimers Dis       Date:  2003-04       Impact factor: 4.472

5.  Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease.

Authors:  R Rademakers; K Sleegers; J Theuns; M Van den Broeck; S Bel Kacem; L-G Nilsson; R Adolfsson; C M van Duijn; C Van Broeckhoven; M Cruts
Journal:  Neurobiol Aging       Date:  2004-12-22       Impact factor: 4.673

6.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

Authors:  D P Hanger; K Hughes; J R Woodgett; J P Brion; B H Anderton
Journal:  Neurosci Lett       Date:  1992-11-23       Impact factor: 3.046

7.  Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.

Authors:  E M Mandelkow; G Drewes; J Biernat; N Gustke; J Van Lint; J R Vandenheede; E Mandelkow
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

8.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

Review 9.  When good Cdk5 turns bad.

Authors:  Qing Guo
Journal:  Sci Aging Knowledge Environ       Date:  2006-02-08

10.  Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.

Authors:  Jonathan C Cruz; Huang-Chun Tseng; Joseph A Goldman; Heather Shih; Li-Huei Tsai
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

View more
  5 in total

Review 1.  Cancer and neurodegeneration: between the devil and the deep blue sea.

Authors:  Hélène Plun-Favreau; Patrick A Lewis; John Hardy; L Miguel Martins; Nicholas W Wood
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

2.  Cyclin-dependent kinase 5 promotes pancreatic β-cell survival via Fak-Akt signaling pathways.

Authors:  Marie Daval; Tatyana Gurlo; Safia Costes; Chang-Jiang Huang; Peter C Butler
Journal:  Diabetes       Date:  2011-03-04       Impact factor: 9.461

3.  No association of CDK5 genetic variants with Alzheimer's disease risk.

Authors:  José Luis Vázquez-Higuera; Ignacio Mateo; Pascual Sánchez-Juan; Eloy Rodríguez-Rodríguez; Jon Infante; José Berciano; Onofre Combarros
Journal:  BMC Med Genet       Date:  2009-07-17       Impact factor: 2.103

Review 4.  Blood-Based Kinase Assessments in Alzheimer's Disease.

Authors:  Jacques Hugon; François Mouton-Liger; Emmanuel Cognat; Julien Dumurgier; Claire Paquet
Journal:  Front Aging Neurosci       Date:  2018-11-14       Impact factor: 5.750

5.  Exploring Kinase Inhibition Properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine Derivatives.

Authors:  Yvonnick Loidreau; Carole Dubouilh-Benard; Marie-Renée Nourrisson; Nadège Loaëc; Laurent Meijer; Thierry Besson; Pascal Marchand
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.